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Abstract
Background: When studying metabolism at the organ level, a major challenge is to understand the matter
exchanges between the input and output components of the system. For example, in nutrition, biochemical models
have been developed to study the metabolism of the mammary gland in relation to the synthesis of milk components.
These models were designed to account for the quantitative constraints observed on inputs and outputs of the
system. In these models, a compatible flux distribution is first selected. Alternatively, an infinite family of compatible set
of flux rates may have to be studied when the constraints raised by observations are insufficient to identify a single flux
distribution. The precursors of output nutrients are traced back with analyses similar to the computation of yield rates.
However, the computation of the quantitative contributions of precursors may lack precision, mainly because some
precursors are involved in the composition of several nutrients and because some metabolites are cycled in loops.
Results: We formally modeled the quantitative allocation of input nutrients among the branches of the metabolic
network (AIO). It corresponds to yield information which, if standardized across all the outputs of the system, allows a
precise quantitative understanding of their precursors. By solving nonlinear optimization problems, we introduced a
method to study the variability of AIO coefficients when parsing the space of flux distributions that are compatible
with both model stoichiometry and experimental data. Applied to a model of the metabolism of the mammary gland,
our method made it possible to distinguish the effects of different nutritional treatments, although it cannot be
proved that the mammary gland optimizes a specific linear combination of flux variables, including those based on
energy. Altogether, our study indicated that the mammary gland possesses considerable metabolic flexibility.
Conclusion: Our method enables to study the variability of a metabolic network with respect to efficiency (i.e. yield
rates). It allows a quantitative comparison of the respective contributions of precursors to the production of a set of
nutrients by a metabolic network, regardless of the choice of the flux distribution within the different branches of the
network.
Keywords: Flux Balance Analysis, Flux distributions exploration, Yield variability, Nutritional model
Background
When studying metabolism, it is important to elucidate
how fluxes are distributed among the different pathways
of the metabolic network with respect to the available
quantitative information about the system behavior. Sev-
eral methods can be used to address this issue. The
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first approach consists of building a mechanistic descrip-
tion of transformations and identifying the regulations
involved in the system. Continuous dynamical models are
often used for this purpose, especially when time-series
responses to different treatments are available to infer the
dynamics of the network. Static approaches such as Petri
net can also identify qualitative distributions of fluxes in
a metabolic network [1], and their stochastic extensions
can even take into account stoichiometric and kinetic
information [2]. With a complementary approach, one
© 2014 Abdou-Arbi et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
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can study a system at the functional level, based on the
study of fluxes at steady states. This is the purpose of
the Flux Balance Analysis (FBA) framework, which has
evolved considerably over the past decades [3,4]. With
an FBA, the identification of external regulations is not
necessary because it is assumed that the global behav-
ior of the system can be modeled by optimizing linear
combinations of selected fluxes (i.e. the objective func-
tion). Roughly, the methods developed in this field aim
to explore a convex space of plausible flux distributions
and to study the extreme flux distributions obtained when
optimizing a linear objective function. It allows check-
ing whether an extreme flux distribution is consistent
with experimental data and to predict new experimen-
tal observations [5-8]. Nonetheless, the consistency of
the solutions obtained by FBA depends on the quality
of the constraints integrated in the model. To overcome
this limitation, several extensions have been proposed
in the literature. These extensions can be broken down
into two parts. The first incorporates additional biolog-
ical knowledge, such as reaction thermodynamics [9] or
multioptimization [10]. The second is based on the use of
FBA to globally analyze large-scale metabolic networks.
For example, in flux variability analysis [11], the minimum
and the maximum flux for each reaction in the network
are computed under some (sub-)optimal conditions.
In this paper, our main purpose is to extend this frame-
work to study the variability of a metabolic network at
the level of efficiencies instead of fluxes. Indeed, when
studying a metabolism at the organ level, a major chal-
lenge consists in comparing the efficiency, or yield rates,
of two metabolic situations, i.e. the response to vari-
ous input patterns. A typical example of such studies are
those concerning animal nutrition, which aim to predict
the quality and quantity of animal production (meat, fat,
milk, etc.) in response to breeding factors. In this field,
the energy and protein conversion efficiencies are derived
from the study of the flux distribution of input nutrients
between the different branches of the metabolic network
[12]. More generally, although its definition depends on
the field of application, the concept of efficiency is often
linked to energy, mass growth and protein conversion
[13-15]. However, the computing of efficiencies is prone
to difficulties and errors, since it requires computing the
quantities precursors sets which are required to explain
the measured composition of outputs, although some of
the internal products may be recycled within cycles [16].
With this goal, we defined the allocation of an input
towards an output (with the abbreviation AIO) to be the
proportion of a matter component (such as carbon) in a
given input flux that is recovered in the selected output
flux. Our definition is based on the choice of a material
component, such as carbon or nitrogen, which allows a
comparison of the contributions of input metabolites to
the composition of output products. It can be seen as
a yield rate, which is uniform among all the outputs of
the system, allowing a precise understanding of the pre-
cursors used. As a first methodological contribution, we
prove that AIO can be uniquely described and computed,
even in the case when there are metabolic system cycles,
by a matrix whose coefficients are nonlinear functions of
the flux variables. Introducing nonlinearity in the defini-
tion of AIO cannot be avoided because of the presence of
these cycles.
Studying the variability of AIO within a complete space
of plausible flux distributions requires the solving of non-
linear optimization problems which are underdetermined
in tangible applications. As a second methodological con-
tribution, we have proposed efficient algorithms to com-
pute lower and upper bounds for AIOs over the fam-
ily of flux distributions which are compatible with both
the system’s stoichiometry and the experimental datasets,
regardless of the choice of a flux distribution for the
internal branches of the network. An important aspect is
that when the metabolic network is provided with input-
output data, the complete space of plausible distributions
appears to have a relatively small size, and can therefore
be studied with our method. Our framework is depicted
in Figure 1.
Our main example of application is related to milk pro-
duction. In this context, several models have been intro-
duced, in relation with the aforementioned classification
of models. One class of small-size dynamical mechanis-
tic models predicts the blood flow and input nutrients
of the metabolic system (i.e. the mammary gland) [17,18]
or, alternatively, the nutrients produced by the metabolic
system (in terms of milk composition) [19,20]. Another
class of models predicts the distribution (i.e. partitioning)
of fluxes over the pathways from the input and output
nutrients of the system [21,22]. In the latter family, both
dynamic and static approaches exist. Indeed, numeri-
cal models based on mass-action equations were initially
proposed to describe the fluxes to and from individual
metabolites, with different levels of description [21,22].
To that goal, optimizers were used to determine a reason-
able set of parameter estimates for the dynamical model of
the system. Although such a set of parameter estimates is
not unique. With a totally different approach, in another
study, the main biochemical pathways in the different
metabolisms were integrated in a generic stoichiometric
model called the metabolic spreadsheet [15,23]. Its struc-
ture was based on a restricted number of intermediary
metabolites called carbon-chain pivots, which correspond
to important cross-over points between metabolic path-
ways. This allowed the computation of the flux rates for all
reactions, constrained by a general rule stating that there
is no accumulation of intermediary metabolite of cofac-
tors. A study of manual calculations performed with the
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Figure 1Main functionalities of the analysis workflow. First, extremal vertices of the simplex polyhedron of plausible flux distributions have to
be computed, including the case when this space is not bounded. Then, formal algebra is required to obtain a symbolic representation of AIO
matrices, expressed as a formal function, where the variables are the coefficients of a plausible flux distribution. Finally, extrema of the AIO
coefficients are computed among the complete simplex of plausible flux distributions, either with the existing optimization routine or with
dedicated local-search algorithms.
metabolic spreadsheet showed that it works, in practice,
by maximizing an objective function (ATP production) in
a convex solution space [24]. Therefore, this model can be
considered as an application of the Flux Balance Analysis
framework [25].
Nonetheless, in this field of study, there has been little
discussion on the impact of the choice of a single model
among several (possibly infinitely many) reasonable mod-
els [14]. To investigate this issue in a more automatic
way, we compared the aforementioned conventional mod-
els to the convex space of plausible flux distributions
associated with steady states of a model of mammary
gland metabolism, as computed in FBA. We checked
the consistency of extreme flux distributions of nutrients
with experimental data of the mammary gland and milk
production, including the contribution of nutrient input-
output and isotope balance studies [26,27]. Based on our
AIO computation framework, our analysis highlighted
that themetabolic behavior of themammary gland cannot
be modeled by maximizing ATP production or by opti-
mizing a linear combination of flux variables of the model
of the mammary gland. In other words, although an infi-
nite number of flux distributions are compatible with the
data, none are extreme within the space of feasible mod-
els. Selecting any of these nonoptimal flux distributions
to predict the system behavior appears difficult without
additional experimentation.
To gain better understanding of the system response
regardless of the choice of a flux distribution for the inter-
nal branches of the network, we applied our method to
estimate the variability of AIO coefficients in our model
and compared the effects of two different diets on mam-
mary gland metabolism. Our results suggest that the
bounds of AIO are sufficient to distinguish the effects of
different nutritional treatments without selecting a flux
distribution for the internal reactions of the metabolic
network by any method - optimization of a linear combi-
nation of fluxes or a residual score. Overall, the complete
study suggests considerable flexibility in mammary gland
metabolism. It provides a view of the functioning of the
system although its internal processes still cannot be clar-
ified because of limitations on experimentation on large
animals such as ruminants.
Results
We first investigated the set of flux distributions that are
compatible with the stoichiometry of our mammary gland
model (depicted in Figure 2), without taking datasets into
account. The model exhibited a large variability, since
thousands of extreme pathways could be identified.
We then successively computed the set of flux distribu-
tions compatible with the model and the real datasets of
lactationmetabolism in dairy cows. The datasets are given
in Table 1. They include a control diet (Ctrl), a diet related
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Figure 2 Simplified view for the stoichiometric model of ruminant mammary metabolism with no long-chain fatty acid oxidation. The
complete model is detailed in a SBML Additional file 1. Eleven nodes are considered as pivots (green nodes), that is, intermediary metabolites which
are not accumulated in the cell. The model is built by adding 26 specific reactions to the ruminant mammary to the generic model of [23]. A
treatment is characterized by a set of input nodes (yellow nodes), quantitatively described in mmol/h/half udder. Nutrients contained in the milk are
considered as output nodes. The node “Fatty acid synthesis” is an abstraction for 14 reactions corresponding to C(4:0), C(6:0), . . . C(16:0) from
primerC2 and primerC4. Note that, depending on the treatment, the role of nonessential amino acids may change from input to output according to
the balance of the amino-acid considered. The node “peptide” summarizes the ATP cost of protein synthesis and protein degradation. Notably, the
stoichiometry of reactions was adjusted in order to balance carbon exchanges, including CO2. This is a key point in order to compute exact allocation
tables in the following stages. Additional literature-based information allows us to generate additional linear constraints on some reactions fluxes.
to an increased protein supply through casein infusion
into the duodenum (CN), and a complementary dataset
(HB) previously used in a mechanistic model of the mam-
mary metabolism [21]. For the three datasets, the set of
plausible flux distributions – solutions to a linear system
detailed in Eq. (1) – was an unbounded convex cone of
dimension 5. In all cases, the solution spaces shared the
same set of five independent variables. This suggests that
there are five independent levels of variability within the
system: peptide hydrolysis (R64), NADPH oxidation (R19),
OAA→PYR (R14), OAA→G3P (R15) and G3P→G6P (R8).
Therefore, by including this dataset the model became
a fairly small and constrained network. Nevertheless, it
was not uniquely determined since there were still several
degrees of freedom.
Investigating the relevance of the optimization strategies
for mammary metabolism
The balance between the ATP generated by the system
and the ATP used by the system (including the ATP cost
of milk component synthesis) was computed for the three
datasets (Ctrl), (CN) and (HB). The results are detailed in
Table 2. In this table, the FBA approach based on opti-
mization of the ATP balance is compared to the natural
functioning of the system.
First, we considered the manual computation of fluxes
with a tool named “metabolic spreadsheet” [15,23]. We
applied the rules of no accumulation on any intermedi-
ary metabolites and cofactors with a utilization rejecting
all the cycles. As expected, since some cycles are ATP-
consuming, both flux distributions were equivalent in
both approaches (Table 2). The ATP balances were respec-
tively 3081, 2045 and 6628 mmol/h/half udder (i.e. 318
mol/d/udder) in the (Ctrl), (CN) and (HB) datasets.
According to this model, the ATP generated is estimated
to be 6500 mmol/h/half udder (i.e. 312 mol/d/udder)
while 2125 mmol/h/half udder (i.e. 102 mol/d/udder)
were estimated to be used for milk component synthesis
[31]. Therefore, the ATP-balance obtained for this model
was slightly smaller than the optimal one obtained for our
mammary gland model.
Independently of the approach considered and the
model or dataset at hand, the remaining ATP (ATP bal-
ance), after use for milk synthesis, appeared to be rather
high and nonxconstant. Indeed, as shown in [31], an ATP
balance of 1250 mmol/h/half udder (60 mol/d/udder) can
be expected to be used for other functions not accounted
for in the models, such as maintaining membrane poten-
tial and synthesizing nucleic acids. The numerical val-
ues obtained here were far from this estimated balance,
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Table 1 Net uptake andmilk component output of themammary gland in three treatments
Input or output flux (Ctrl) [28,29] (CN) [28,29] (HB) [21]
mmol/h/
half udder
mmol/h/
half udder
mol/d/
udder
mmol/h/
half udder
v2 Glucose input
(1) 237 232 12.21 254
v95 Glycerol input 5.84 5.74 0.033 0.69
v96 Acetate input 510 462 18.42 384
v97 BHBA input
(2) 84 167 7.25 151
v98 Lactate input 0 0 0.023 0.48
v62 3C(n:m)-acycoA+glycerol- 32.96 39.11 1.52 31.67
3P→ triglyceride (3) output (4)
Fatty acid output (synthezized)(5)
v100 C(4:0) 10.08 11.59 0.46 9.48
v101 C(6:0) 4.51 5.58 0.18 3.79
v102 C(8:0) 2.23 2.87 0.10 2.06
v103 C(10:0) 4.66 6.46 0.19 3.96
v104 C(12:0) 4.23 6.12 0.17 3.56
v105 C(14:0) 13.90 17.89 0.45 9.31
v106 C(16:0) 18.82 21.44 0.64 13.40
v99 Lactose output 73.80 83.52 3.81 79.28
Amino acids balance(6) i.e. entry or output
v128 Alanine input 3.11 0 0.105 2.19 Alanine catabolism
v121 Alanine output 0 3.26 0 0 Alanine synthesis
v119 Arginine input 4.40 4.48 0.526 10.96 Arginine catabolism
v134 Asparagine output 0 0 0.023 0.48 Asparagine synthesis
v125 Aspartate output 3.43 4.13 0.247 5.15 Aspartate synthesis
v122 Glutamate output 0.54 6.33 0.230 4.79 Glutamate synthesis
v131 Clutamine input 1.22 1.79 0.072 1.50 Glutamine catabolism
v120 Glycine output 4.98 3.44 0.248 5.17 Glycine synthesis
v124 Proline output 10.65 10.99 0.670 13.96 Proline synthesis
v136 Serine output
(7) 7.21 7.50 0.090 1.88 Serine synthesis - Serine
used in other pathways
v118 Histidine input 0.23 0 0 0 Histidine catabolism
v113 Isoleucine input 2.19 3.57 1.518 31.63 Isoleucine catabolism
v114 Leucine input 2.02 3.76 0 0 Leucine catabolism
v108 Lysine input 2.68 3.58 0.191 3.98 Lysine catabolism
v111 Threonine input 0.35 0 0 0 Threonine catabolism
v115 Valine input 2.54 3.86 0.438 9.13 Valine catabolism
v107 Peptide output
(8) 124.5 150.0 7.2 149.17
Additional constraints
v82 NADPH through ICDH pathways
(9) 30% 30% 30% 30%
v58 =
0.7
0.3 v82 NADPH through Pentose Phosphate
(9) 70% 70% 70% 70%
v56 = 3v62 C(n:m)→C(n:m)-acylCoA 98.87 117.32 4.56 95.00
FA primer from Acetate(10)
v53 C(4:0) 0 0 0 0
v54 = v90 C(6:0) 2.256 2.790 0.091 1.896
v55 = v91 C(8:0) 1.113 1.437 0.050 1.031
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Table 1 Net uptake andmilk component output of themammary gland in three treatments (Continued)
v51 = v52 C(10:0) 2.331 3.230 0.095 1.979
v86 = v92 C(12:0) 2.116 3.061 0.086 1.781
v87 = v93 C(14:0) 6.951 8.946 0.223 4.655
v88 = v94 C(16:0) 9.410 10.719 0.322 6.698
Other constraints(11)
v24 Lactate→Pyruvate 0 0
v44 Alanine catabolism 0
v76 Alanine synthesis 0 0 0
v83 Asparagine synthesis 0 0
v40 Histidine catabolism 0 0 0
v36 Leucine catabolism 0 0
v33 Threonine catabolism 0 0 0
Data are renormalized in mmol/h/half udder. (a) Control diet (Ctrl) [28,29] (b) Higher protein supply by casein infusion in the duodenum (CN) [28,29] (c) Generic
dataset (HB) [21]. This table is used to parameterize input and output vectors vI and vO together with additional biological linear constraints on some reaction fluxes.
1 Input i.e. taken up by the stoichiometric system considered (i.e.net uptake in our example for the mammary gland).
2β-Hydroxybutyrate.
3Total triglycerides secreted in milk considering that milk fat was composed of 100% triglycerides and that all the triglycerides were secreted in milk fat [21].
4Output i.e. leaving the system (secreted in milk).
5All fatty acids synthesized within the mammary gland i.e. all C4 to C14 and 50% of C16 [21].
6The balance between amino acid net uptake and amino acid net output in milk protein is calculated with established rules [21,30]. If the balance is positive it
corresponds to an amino acid input that will be catabolized. If this balance is negative, the values corresponded to an amino acid output (that will be synthesized to
meet its requirement for milk protein).
7Serine output corresponded to Serine synthesized minus Serine utilized in other pathways i.e. Serine required in addition to Ser uptake to synthesize milk protein.
8Peptide output: number of peptide links required to synthesize the proteins exported out of the system (i.e. in milk protein).
9Hanigan, 1994 [21].
10Fatty acid primers were synthesized for 50% from acetate and for 50% from BHBA except C4 FA primer which was supposed to be synthetized only from BHBA [21].
11Set at zero because their inputs or outputs are set at zero (to avoid futile cycle).
Table 2 Three different computations of ATP balance for
themammary gland in different treatments
Biological model Dataset ATP balance Proteic
Criteria of selection of a
solution
turnover
Mammary-gland model
(Figure 3)
(HB) 6628 0
Manual study based on
cycle removal [23]
(Ctrl) 3081 0
(CN) 2045 0
Mammary-gland model
(Figure 3)
(HB) 6628 0
ATP optimization (Ctrl) 3081 0
(CN) 2045 0
Model of Hannigan-
Baldwin [21]
(HB) 4375 = 6500-2125 0
Study of numerical
equilibria of an ODE
model [31]
(Ctrl) Non available
(CN) Non available
Three natural assumptions are considered to model the mammary gland
behavior: removal of all cycles, optimization of ATP production and study of the
equilibria of a dedicated ODE-based model. All models exhibit considerable
variability in their ATP balance (in mmol/h/half udder), which contradicts the
assumption about the behavior of this organ. Moreover, quantitatively, the
computed ATP balances are much higher than recent measurements. This
suggests that ATP maximization cannot be considered as a natural objective
function to model cowmammary behavior.
suggesting that each of these three models have a nonrel-
evant ATP balance.
In addition, both in the ODE model and the ATP-
optimization approach, peptide hydrolysis was obtained
at zero, implying an absence of any protein turnover. This
contradicts all the observations about this pathway: con-
siderable use of this pathway has been evidenced in several
publications, although the peptide hydrolysis rates dif-
fered significantly depending on the technique used for
the measurements: peptide hydrolysis (R64 i.e. mammary
protein degradation) spans from 0.25, 0.23 to 0.67 of pep-
tide synthesis (R63 i.e. total mammary protein synthesis)
in (Ctrl), (CN) and (HB), respectively [29,31].
Overall, we concluded with this analysis that the energy-
based optimization function may not allow an appro-
priate simulation of mammary gland metabolism. This
was expected, considering that the system is studied at
the complete organ level, involving competing processes
which can rarely be modeled with a single linear objective
function.
Exploring all extreme flux distributions in a refined simplex
In order to study the variability within the space of plau-
sible flux distributions and to identify alternative rele-
vant optimization strategies, an additional constraint was
placed on the ATP balance of the system. We considered
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that an ATP-balance of 1250 mmol/h/half udder (60
mol/d/udder) was a relevant measure for this study [31],
although we checked that all the results discussed below
were still valid when introducing a 10% tolerance on
this estimation of ATP-balance. Providing a bound for
ATP yielded a new constraint on several variables of
the system. For the two datasets (Ctrl) and (CN), the
flux G3P→G6P (R8) was no longer an independent vari-
able in the system. The simplex, which was previously
unbounded, appeared to be bounded with four inde-
pendent variables: OAA→PYR (R14), OAA→G3P (R15),
NADPH oxidation (R19), peptide hydrolysis (R64).
Applying flux variability tools [32], it appeared that
the minimum of each of the fluxes v14, v15, v19, v64 was
equal to zero for all treatments. The maxima of the fluxes
(v14, v15, v19, v64) were (1831, 1831, 669, 305) for the (Crtl)
treatment and (795, 795, 22, 133) for the (CN) treatment
This suggests that the (Ctrl) treatment generates a more
flexible space of plausible flux distributions than the (CN)
treatment.
We computed all extreme vertices of the simplex of
plausible flux distributions for the two treatments (Ctrl),
(CN). The simplex structure of the polyhedron implies
that the optimum of any linear combination of metabolic
fluxes involved in the model is either uniquely attained
for one of these extreme points or attained by all flux dis-
tributions positioned on a face of the simplex. To gain
insight on the pathways involved in the variability of
our model, we also computed the linear combination of
fluxes optimized for one of the extreme flux distributions.
Eight extreme vertices were found for the (Ctrl) and (CN)
datasets. They were obtained when optimizing the same
set of linear functionsa. In Table 3, the optimal flux distri-
butions for (Ctrl), (CN) are classified according to the acti-
vation or inactivation of several pathways in the model.
It is worth noting that, according to this table, the two
sets of plausible flux distributions associated with (CN)
and (Ctrl) have the same topological structure. Indeed, the
eight extremal behaviors for (CN) and (Ctrl) have clear
combinatorics: first, NADPH oxidation is set either at
zero or at its maximal value. Then, a single flux within
OAA→PYR (R14), OAA→G3P (R15), G3P→G6P (R8),
peptide hydrolysis (R64) is strongly activated whereas the
three other remaining fluxes are blocked.
As discussed in a previous paragraph, flux distributions
with no peptide hydrolysis cannot be considered as rele-
vant [28,31]. This suggests the extreme flux distributions
A-F in (CN) and (Ctrl) are not biologically relevant. On
the contrary, two extreme flux distributions (distributions
G and H) are consistent with the stoichiometry of the sys-
tem for the (CN) and (Ctrl) treatments. These two flux
distributions consist in optimizing peptide synthesis and
hydrolysis after NADPH oxidation. They corresponded to
a ratio between peptide hydrolysis and synthesis v64v63 of
0.70 in the (Ctrl) treatment and of 0.47 in the (CN) treat-
ment. These ratios are equal or lower to the maximum
ratio of 0.67v63 [31]. However, in (CN), treatment peptide
synthesis was expected to be higher than in Ctrl treat-
ments since in mammals protein synthesis is reported to
increase with increasing protein intake (as CN in treat-
ment) [29]. Curiously, on the contrary, in both flux dis-
tributions G and H, the total mammary protein synthesis
decreased for the (CN) treatment when compared to the
(Ctrl) treatment: v63 equals 430 or 410 mmol/h/half udder
in (Ctrl) and 283 or 282 mmol/h/half udder in (CN).
Study of quantitative contributions of precursors (AIO) for
plausible extreme flux distributions
As a further investigation to check the relevance of dis-
tributions G and H in the (CN) and (Ctrl) treatments,
we studied the quantitative contributions of precursors
of output nutrients. This study was inspired by the usual
techniques in the field of nutrition - or any domain con-
cerned with organ studies. These techniques consist in
computing yield rates to elucidate how an input nutrient
may contribute to the composition of an output product,
for instance to clarify what proportion of glucose, acetate
or alanine taken up by the mammary gland can be recov-
ered in the milk components (lactose, fatty acids, protein)
or oxidized and recovered in CO2 released in blood. To
formalize this issue, we first selected carbon as the compo-
nent according to which the contributions of precursors
were to be computed. Then, in order to determine how
much carbon introduced into the system through a given
input flux can be recovered in the rate of production of
an output metabolite, we introduced a precise model for
the allocation of nutrients in measured outputs (AIO) (see
Eq. (3)). As shown in Tables 4 and 5, the nutrient allo-
cation corresponding to both flux distributions G and H
in the (CN) and (Ctrl) treatments provides evidence that
glucose is the unique precursor of lactose synthesis. This
contradicts studies of dairy cows suggesting that glycerol
and perhaps amino acids contribute to lactose synthesis
[26], and that fifteen percent of lactose carbon could not
derive from glucose [27].
This precise analysis of the origin of carbon in lactose
synthesis with AIO suggests that extreme flux distribu-
tions G and H have to be rejected, although both flux
distributions are consistent with flux variability criteria.
We concluded that none of the extreme vertices of the
set of plausible flux distributions could be considered bio-
logically relevant with respect to the model and data at
hand. Notice that the optimization of any linear com-
bination of metabolic fluxes is either reached by these
extreme distributions or reached by the infinite number
of flux distributions lying in a face of the simplex. This
suggests that the functioning of the mammary gland can-
not be uniquely modeled by the optimization of any linear
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Table 3 Main properties of the simplex vertices under the assumption of constant ATP-production
Dataset Model name Example of Combinatorics of pathways Validation Pathways with
maximized nonrelevant flux
function R19 R15 R14 R8 R64 R63 R13 values
NADPH OAA→G3P OAA→PYR G3P→G6P Peptide Peptide Pyr → OAA
oxidation hydrolysis synthesis
Extreme flux
distributions
within the set of
plausible
solutions
(Ctrl)
B v15-v19 0
1831
0 0 0
125 1835
R13 ,R64
(CN) 795 150 803
(Ctrl)
F v14-v19 0 0
1831
0 0
125 1835
R13 ,R64
(CN) 795 150 803
(Ctrl)
D v8-v19 0 0 0
3662
0
125 4
R8 ,R64
(CN) 1590 150 8
(Ctrl)
H v64-v19 0 0 0 0
305 430 4
(CN) 133 283 8
(Cntl)
A v15+v19
694 1714
0 0 0
125 1718
R13 ,R64
(CN) 22 791 150 799
(Ctrl)
E v14+v19
694
0
1714
0 0
125 1718
R13 ,R64
(CN) 22 791 150 799
(Ctrl)
C v8+v19
694
0 0
3428
0
125 4
R8 ,R64
(CN) 22 1583 150 8
(Ctrl)
G v64+v19
669
0 0 0
286 410 4
(CN) 22 132 282 8
Litterature-based upperbounds for fluxes ≤ 591 Non-zero Lower than ≤ 266 mmol/h/half
mmol/ [28,31] whole body udder [33]
h/half udder [33] protein synthesis [29]
The qualitative properties of all vertices are shared in (Ctrl) and (CN) treatments. Both correspond to a simplex with height vertices. So are six of each of the (Ctrl) and (CN) simplex vertices. H and G vertices, in the (Ctrl) and
(CN) treatments, are plausible with respect to the literature.
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Table 4 Origin of carbonmass within outputs for the two optimal flux distributions shown in Table 3
Origin of carbonmass in outputs for (Ctrl) treatment
Input GLC Glycerol Acetate BHBA Lys Threonine Isoleucine Leucine Valine Histidine Arginine Alanine Glutamine
Origin of the carbonmass of each output within input (in percentage of total carbonmass of each output)
Output
Model (G) (H) (G) (H) (G) (H) (G) (H) (G) (H) (G) (H) (G) (H) (G) (H) (G) (H) (G) (H) (G) (H) (G) (H) (G) (H)
Glycerol3P 87.4 95.3 12.6 4.7 0 0 0 0 0 0 0 0 0 0 0
lactose 100.0 0 0 0 0 0 0 0 0 0 0 0 0
C4 0 0 0 100.0 0 0 0 0 0 0 0 0 0
c6 0 0 66.7 33.3 0 0 0 0 0 0 0 0 0
c8 0 0 75.0 25.0 0 0 0 0 0 0 0 0 0
c10 0 0 80.0 20.0 0 0 0 0 0 0 0 0 0
c12 0 0 83.3 16.7 0 0 0 0 0 0 0 0 0
c14 0 0 85.7 14.3 0 0 0 0 0 0 0 0 0
c16 0 0 87.5 12.5 0 0 0 0 0 0 0 0 0
Glycine 73.0 78.3 9.2 3.7 9.7 9.8 4.0 4.1 0.3 1.4 0.3 0.2 0.3 0.8 0.4 0.2 0.1
Glutamate 1.3 17.2 0.2 0.8 61.5 51.2 25.5 21.3 1.4 1.1 0.1 1.7 1.4 1.6 1.3 1.3 1.1 0.2 0.1 3.4 2.8 1.0 0.7 0.9 0.8
Proline 1.3 17.2 0.2 0.8 61.5 51.2 25.5 21.3 1.4 1.1 0.1 1.7 1.4 1.6 1.3 1.3 1.1 0.2 0.1 3.4 2.8 1.0 0.7 0.9 0.8
Aspartate 1.8 17.6 0.2 0.9 60.1 50.3 25.0 20.9 1.3 1.1 0.1 2.2 1.9 1.5 1.3 2.0 1.6 0.2 0.1 3.3 2.8 1.4 0.7 0.9 0.8
Peptide 0 0 0 0 0 0 0 0 0 0 0 0 0
SERoutput 84.8 92.5 12.2 4.6 0.0 0.0 0.0 1.8 0.0 0.0 0.0 1.1 0.0 0.0 0.0
CO2Output 37.6 35.7 0.1 1.0 38.7 39.3 16.1 16.3 1.3 1.4 0.1 1.1 1.0 1.0 1.1 0.1 1.7 1.8 0.8 0.5
Both models have empty flux through the reactions OAA→ PYR (R14), OAA→ G3P (R15) and G3P→ G6P (R8). Model (G) shows strong NADPH oxidation whereas model (H) has zero NADPH oxidation.
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Table 5 Origin of carbonmass within outputs for the two optimal flux distributions shown in Table 3
Origin of carbonmass in outputs for (CN) treatment
Input GLC Glycerol Acetate BHBA Lys Isoleucine Leucine Valine Arginine Glutamine
Origin of the carbonmass of each output within input
(in percentage of total carbonmass of each output)
Output
Model (G) (H) (G) (H) (G) (H) (G) (H) (G) (H) (G) (H) (G) (H) (G) (H) (G) (H) (G) (H)
Glycerol3P 90.3 90.7 9.7 9.3 0 0 0 0 0 0 0 0 0
Lactose 100.0 0 0 0 0 0 0 0 0 0 0
C4 0 0 0 100.0 0 0 0 0 0 0
c6 0 0 66.7 33.3 0 0 0 0 0 0
c8 0 0 75.0 25.0 0 0 0 0 0 0
c10 0 0 80.0 20.0 0 0 0 0 0 0
c12 0 0 83.3 16.7 0 0 0 0 0 0
c14 0 0 85.7 14.3 0 0 0 0 0 0
c16 0 0 87.5 12.5 0 0 0 0 0 0
Glycine 73.8 74.1 7.3 7.0 5.6 10.8 0.5 0.5 0.5 0.4 0.5 0.2
Alanine 90.3 90.7 9.7 9.3 0 0 0 0 0 0 0 0
Glutamate 2.5 3.0 0.2 0.3 28.7 28.6 56.1 55.8 1.6 2.4 2.5 1.7 3.0 1.2
Proline 2.5 3.0 0.2 0.3 28.7 28.6 56.1 55.8 1.6 2.4 2.5 1.7 3.0 1.2
Aspartate 3.8 4.3 0.4 27.8 27.6 54.2 53.9 1.6 1.5 3.2 2.4 2.6 2.9 1.2
Peptide 0 0 0 0 0 0 0 0 0 0
SERoutput 90.3 90.7 9.7 9.3 0 0 0 0 0 0 0 0
CO2Output 24.2 24.1 0.2 22.2 43.4 1.9 1.8 2.0 1.7 1.9 0.8
Both models have empty flux through the reactions OAA→ PYR (R14), OAA→ G3P (R15) and G3P→ G6P (R8). Model (G) shows strong NADPH oxidation whereas model (H) has zero NADPH oxidation.
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combination of metabolic fluxes involved in the current
model.
Discriminate treatments despite mammary gland
flexibility: maxima of AIO on the complete polyhedron of
flux distributions
Previous studies suggest that the response of the mam-
mary gland cannot be modeled uniquely by the optimiza-
tion of a linear objective function of fluxes. However,
there are several nonoptimal flux distributions that sat-
isfy the literature-based information that we have used
so farb. More generally, many flux distributions compat-
ible with the additional constraints, including the con-
dition on carbon precursors for lactose can be shown
for both (CN) and (Ctrl) treatments. Topological argu-
ments prove that an infinite set of flux distributions exist.
Nonetheless, without an idea about the exact shape of
the space of feasible fluxes (because of the nonlinear
nature of the condition of carbon precursors), we can-
not select a plausible point within this space. In other
words, the available knowledge appears insufficient to
determine uniquely a flux distribution of nutrients among
the different branches of the proposed model.
To understand the functioning of the mammary gland
and despite this difficulty, we introduced a method to
estimate the variability of nutrient allocation among path-
ways on a carbon basis (see Eq. (3)) by computing the
range (min-max) of AIO coefficients. As these coefficients
are nonlinear functions of flux variables, computing these
min and max over the complete space of plausible flux
distribution requires solving nonlinear optimization prob-
lems. Our dedicated algorithm detailed in the method
section scaled properly to the real case that we are study-
ingc. Interestingly, with this approach, we did not favor
any internal functioning of the system since we parsed all
objective functions (linear combinations of flux variables),
in order to have a complete description of the space of
plausible flux distributions.
The min-max tables for allocations of nutrients in the
different pathways provided a clearer view of nutrient
utilization within the mammary gland. Unlike the func-
tioning of the extremal distributions (G) and (H) shown in
Tables 4 and 5, the contribution of carbon from glucose
to lactose carbon was quite variable within the full set of
plausible distribution. Indeed, as shown in Tables 6 and 7,
glucose was the precursor of 85% ( 1751886 or
866
1002 ) to 100%
of the carbon lactose in the (Ctrl) and (CN) treatments.
Therefore, there exist flux distributions such that glucose
is not the only precursor of lactose synthesis [26], and
these distributions are consistent with quantitative esti-
mations of the ratio of carbon glucose recovered in lactose
[27].
More generally, the intervals of distributions of nutri-
ents in different pathways were used to compare the
effects of the (Ctrl) and (CN) treatments. Biologically, in
comparison to the (Ctrl) treatment, the (CN) treatment
was characterized by a lower proportion of glucose (on a
carbon basis) which is oxidized in CO2, and a larger ratio
used for lactose synthesis. This hypothesis can be sus-
tained since the intervals of distribution of carbon from
glucose in CO2 and lactose almost did not overlap in the
(Ctrl) and (CN) treatments. More precisely, in the (Ctrl)
treatment, from 3961422 = 27.9% to
565
1422 = 39.7% of glu-
cose carbon was oxidized to produce CO2, whereas this
ratio ranged from 17.5% to 28.9% for the (CN) treatment.
In addition, in the (Ctrl) treatment, 52.8% to 62.3% of the
glucose carbon was required to produce lactose carbon,
whereas 62.2% to 72% of glucose was required during the
(CN) treatment.
Altogether, this analysis allowed us to discriminate the
effects of the different treatments whatever the internal
functioning of the system may be: the (CN) treatment
(increase in protein supply to cows) was characterized
by a lower proportion of glucose oxidized in CO2 than
in (Ctrl). It appears to be a suitable strategy to analyze
the metabolism flexibility without selecting a precise flux
distribution or making any assumption on the internal
metabolic fluxes.
As a final study, we used an interior point exploration
method to estimate the AIO variability over the bound-
ary of the simplex, rather than the complete space that
was explored previously. As both tables appeared to be
equal, we concluded that optimized AIO are reached on
the boundary of the simplex. However, not all extreme
vertices of the simplex are relevant biologically and they
do not optimize AIO. This suggests that the flux distri-
butions that optimize an AIO coefficient are placed at
the interior of the simplex faces. In the future, it may be
interesting to study the biological significance with multi-
objective approaches [34] and check whether these can be
considered as a “characteristic” point of these faces.
Impact of long-chain fatty acids oxidation over the model
predictions
As a last study, we studied the robustness of our conclu-
sion with respect to changes in the modeling of input (net
uptake) of long-chain fatty acids (LCFA), C16 and C18,
in the tricarboxylic acid (TCA) cycle. In the study of the
(Ctrl) and (CN) treatments, such an input of LCFA was
not considered in the system since they are not synthe-
sized by the mammary gland and we hypothesized that
they are not oxidized within the mammary gland, based
on isotope measurements in studies in fed lactating goats
and in nonruminants [35-37]. This hypothesis was sus-
tained by the measured carbon balance in the (Ctrl) and
(CN) datasets [28], which did not require increasing the
prediction of CO2 by introducing any LCFA in the TCA
cycle (see also Table 8). Nonetheless, in other contexts and
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Table 6 Minimum andmaximum utilization of input in each output
(Ctrl) treatment
Input Glucose Glycerol Acetate BHBA Lysine Threonine1 Isoleucine1 Leucine1 Valine1 Histidine1 Arginine1 Alanine1 Glutamine1
1422 17,5 1020 336 16,1 1,40 13,1 12,1 12,7 1,38 26,4 9,33 6,10
Output Minimum andmaximum utilisation of Input in each output (in mmol/h/half udder of Carbon)
Min Max Min Max Min Max Min Max Min Max Min Max Min Max Min Max Min Max Min Max Min Max Min Max Min Max
Glycerol3P 98.9 32.9 97.0 1.24 12.5 0 38.4 0 16.0 0 1.1 0 0.1 0 1.3 0 1.0 0 1.2 0 0.1 0 2.0 0 1.0 0 0.6
Lactose 886 751 886 0 7.7 0 79.8 0 33.2 0 2.3 0 0.1 0 2.6 0 2.0 0 2.4 0 0.2 0 4.0 0 2.0 0 1.1
C4 40.3 0 0 0 40.3 0 0 0 0 0 0 0 0 0
c6 27.1 0 0 18.0 9.0 0 0 0 0 0 0 0 0 0
c8 17.8 0 0 13.4 4.5 0 0 0 0 0 0 0 0 0
c10 46.6 0 0 37.3 9.3 0 0 0 0 0 0 0 0 0
c12 50.8 0 0 42.3 8.5 0 0 0 0 0 0 0 0 0
c14 195 0 0 167 27.8 0 0 0 0 0 0 0 0 0
c16 301 0 0 263 37.6 0 0 0 0 0 0 0 0 0
Glycine2 10.0 3.5 8.0 0.1 0.9 1.0 3.7 0.4 1.5 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.1
Glutamate2 2.7 0.0 1.1 0.0 0.1 1.0 1.6 0.4 0.7 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1
Proline2 53.3 0.7 20.8 0.0 0.7 20.0 32.4 8.3 13.5 0.5 0.7 0.0 0.1 0.4 0.9 0.5 0.8 0.3 0.7 0.0 0.1 1.0 1.8 0.2 0.6 0.3 0.5
Aspartate2 13.7 0.2 7.4 0.0 0.3 3.8 8.2 1.6 3.4 0.1 0.2 0.0 0.1 0.1 0.3 0.1 0.2 0.1 0.3 0.0 0.1 0.2 0.4 0.0 0.2 0.0 0.1
Serine2 21.6 7.0 20.6 0.3 2.6 0.0 8.2 0.0 3.4 0.0 0.2 0.4 0.4 0.0 0.3 0.0 0.2 0.0 0.3 0.2 0.3 0.0 0.4 0.0 0.2 0.0 0.1
CO2 1126 396 565 1.3 14.5 343 446 142 185 12.1 15.3 0.7 0.8 9.1 12.4 8.7 11.3 9.1 12.1 0.7 1.0 15.1 20.3 6.3 8.8 4.2 5.6
A local-search algorithm allowed us to compute the minima and maxima of each AIO coefficient for the two treatments (Ctrl), (CN) (in mmol/h/half udder of Carbon). These tables allow discriminating the response of the
mammary gland to the two treatments without requiring selection of a flux distribution for reactions in the metabolic network. (CN) treatment (protein intake by food) is characterized by a lower proportion of glucose which
is oxidized in CO2 than in (Ctrl).
(1)Amino acid input corresponded to positive balances between amino acid net uptake and amino acid and utilization in milk protein (i.e. peptide output).
(2)Amino acid Output corresponded to negative balance between, amino acid net uptake and utilization in milk protein (i.e. peptide output).
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Table 7 Minimum andmaximum utilization of input in each output
(CN) treatment
Input Glucose Glycerol Acetate BHBA Lysine1 Isoleucine1 Leucine1 Valine1 Arginine1 Glutamine1
1392 17.2 924 668 21.5 21.4 22.6 19.3 26.9 8.95
Output Minimum andmaximum utilisation of input in each output (in mmol/h/half udder of Carbon)
Min Max Min Max Min Max Min Max Min Max Min Max Min Max Min Max Min Max Min Max
Glycerol3P 117 36.1 115 1.8 11.3 0 22.8 0 44.5 0 1.6 0 2.3 0.0 2.0 0.0 2.0 0.0 2.2 0.0 0.9
Lactose 1002 866 1002 0 9.2 0 37.9 0 74.0 0 2.6 0 3.9 0.0 3.3 0.0 3.3 0.0 3.7 0.0 1.5
C4 46.4 0 0 0 46.4 0 0 0 0 0 0
C6 33.5 0 0 22.3 11.2 0 0 0 0 0 0
C8 23.0 0 0 17.2 5.7 0 0 0 0 0 0
C10 64.6 0 0 51.7 12.9 0 0 0 0 0 0
C12 73.4 0 0 61.2 12.2 0 0 0 0 0 0
C14 250 0 0 215 35.8 0 0 0 0 0 0
C16 343 0 0 300 42.9 0 0 0 0 0 0
glycine2 6.9 2.1 5.5 0.0 0.5 0.4 1.3 0.7 2.6 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1
Alanine2 9.8 1.4 9.6 0.0 0.9 0 2.4 0 4.7 0 0.2 0 0.3 0 0.2 0 0.2 0 0.2 0 0.1
glutamate2 31.7 0.8 8.8 0.0 0.4 6.7 9.0 13.0 17.6 0.4 0.5 0.4 0.7 0.6 0.8 0.3 0.5 0.7 0.9 0.3 0.4
proline2 55.0 1.4 15.3 0.0 0.6 11.6 15.6 22.6 30.5 0.7 0.9 0.8 1.3 1.0 1.4 0.5 0.9 1.2 1.6 0.5 0.7
aspartate2 16.5 0.6 7.0 0.0 0.3 2.7 4.5 5.3 8.9 0.2 0.3 0.3 0.5 0.2 0.4 0.2 0.4 0.3 0.5 0.1 0.2
serine2 22.5 6.9 22.0 0.3 2.2 0 4.4 0 8.5 0 0.3 0 0.4 0 0.4 0 0.4 0 0.4 0 0.2
CO2 1021 244 402 2.0 12.5 180 227 351 444 16.3 19.8 14.2 19.1 15.8 20.0 13.4 17.4 14.8 19.2 5.9 7.8
A local-search algorithm allowed us to compute the minima and maxima of each AIO coefficient for the two treatments (Ctrl), (CN) (in mmol/h/half udder of Carbon). These tables allow discriminating the response of the
mammary gland to the two treatments without requiring selection of a flux distribution for reactions in the metabolic network. (CN) treatment (protein intake by food) is characterized by a lower proportion of glucose which
is oxidized in CO2 than in (Ctrl).
(1)Amino acid input corresponded to positive balances between amino acid net uptake and amino acid and utilization in milk protein (i.e. peptide output).
(2)Amino acid Output corresponded to negative balance between, amino acid net uptake and utilization in milk protein (i.e. peptide output).
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Table 8 Effect of long-chain fatty acids (LCFA) oxidization in the triacarboxylic acid (TCA) cycle over model analysis
Main characteristics of models with different ratios of LCFA oxidized in TCA
Model CO2 prediction ATP ATP = 1250mmol/h/half udder
optimum Extreme flux distribution (see Table 9) Variability of AIO coefficients
Ratio of Dataset Predicted Ratio of Total number Nonplausible Nonplausible Glucose carbon Glucose carbon
long-chain FA CO2 predicted CO2 flux values AIO required to oxidized
oxidated in TCA andmeasured CO2 produce lactose
0%
(HB) 1546 Non available 6628 Nonrelevant hypothesis [20-22]
(CN) 1021 99% 2045 8 6 2 [62.2 ; 72.0] [17.5 ; 28.9]
(Ctrl) 1126 121% 3081 8 6 2 [52.8 ; 62.3] [27.8 ; 39.7]
10%
(HB) 1640 Non available 7395 13 13 0 [47.7 ; 62.4] [28.8 ; 45.9]
(CN) 1107 107% 2739 8 6 2 [59.4 ; 72.0] [17.5 ; 32.0]
(Ctrl) 1202 129% 3701 8 6 2 [51.6 ; 62.3] [27.9 ; 41.2]
20%
(HB) 1756 Non available 8336 13 13 0 [46.9 ; 62.4] [29.0; 47.0]
(CN) 1214 118% 3607 8 6 2 [57.3 ; 72.0] [17.5 ; 34.6]
(Ctrl) 1298 140% 4476 Nonrelevant hypothesis: predicted CO2 is not compatible with measured CO2 [28]
25%
(HB) 1826 Non available 8396 13 13 0 [46.5; 62.4] [29.0; 47.5]
(CN) 1279 124% 4128 8 6 2 [56.3 ; 72.0] [17.6 ; 35.8]
(Ctrl) 1355 146% 4938 Nonrelevant hypothesis: predicted CO2 is not compatible with measured CO2 [28]
ATP balance Extreme distributions are For plausible ratios of long-chain
is too high not biologically relevant FA in TCA, (CN) treatment is
characterized by a lower proportion
of glucose (on a carbon basis)
which is oxidized in CO2, and
a larger ratio used for lactose synthesis.
To study the impact of the variability of FA oxidation, a ratio of long-chain FA (10%, 20%, 25%) was introduced in the TCA cycle. For datasets (CN), (Ctrl) and (HB) which were compatible with a given ratio of LCFA oxidation,
extreme flux distributions and AIO coefficients variability were studied. Our main conclusions are robust to the introduction of LCFA oxidation (Table 8). Interestingly, as shown in Table 9, the structure of the simplex
generated by the (HB) diet is more complicated than the (Ctrl) and (CN) treatments, with 13 vertices for all hypotheses. This is due to the fact that R15 is highly constrained by measurements, so that this flux cannot vanish
when R14 is optimized or when R19 is maximized. All the vertices for the (HB)-simplex contradict knowledge-based literature.
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models, LCFA oxidation was either measured in starva-
tion condition [38] or introduced in order balance carbon
consumption and production with respect to CO2 pre-
diction [18,20-22]. This LCFA oxidation hypothesis was
for instance retained in models studying the (HB) dataset
[20,21].
From this literature study, it appears that LCFA oxida-
tion may depend on both the environmental and experi-
mental contexts, and no single model can be favored yet.
To study the impact of LCFA oxidation, we successively
introduced a ratio of LCFA in the TCA cycle (10%, 20%,
25%), and assumed that 50% of C16 output are synthesized
within the mammary gland [21] (see Figure 3). Then we
performed a complete study of the (Ctrl), (CN) and (HB)
datasets for these hypotheses (see Tables 8 and 9).
For the (Ctrl) treatment, by comparing the predicted
and measured CO2 quantities, we concluded that the
hypotheses of 20% and 25% of FA oxidized in the TCA
cycle were not in agreement with our experimental data:
the increase of CO2 prediction was too large both when
compared to measured CO2 (see Table 8) and when con-
fronted to the measured increase of 9% of CO2 deriving
from long LCFA in lactating goats in an extreme star-
vation condition [38]. Similarly, the hypothesis of 0% of
LCFA oxidation was not consistent with the (HB) treat-
ment [22].
For all remaining compatible pairs of model and
datasets, we first studied the ATP maximization hypothe-
sis. In all cases, our results, shown in Table 8, suggest that
ATP maximization is not biologically relevant: ATP bal-
ance was even larger than the ATP balance of the models
where no LCFA was introduced in the TCA cycle (0%).
Then we enumerated extreme flux distributions and
studied their biological relevance. As shown in Table 9,
for each ratio of LCFA in the TCA cycle, the struc-
ture of the simplex of plausible flux distributions for the
(Ctrl) and (CN) datasets was similar to that shown in
Table 3 (0%). Using similar arguments, no extreme dis-
tribution could be considered as biologically relevant.
When studying the space of solution associated with the
(HB) dataset, a more complex structure appeared, based
on 13 extreme flux distributions instead of 8. Explicit
(although not unique) linear functions that can be opti-
mized to obtain these extreme distributions are detailed in
Table 9d. More precisely, for the (HB) treatment, we still
obtain a division according to the activation of the four
fluxes OAA→PYR (R14), OAA→G3P (R15), G3P→G6P
(R8), peptide hydrolysis (R64). Nonetheless, an intricate
phenomenon appears. Indeed, measurements imply that
OAA→G3P (R15) is very constrained. It cannot vanish at
the same time as OAA→PYR (R14) or when NADPH oxi-
dation (R19) is at its maximal value. Therefore, for several
optimal conditions related to NADPH oxidation (R19),
OAA→PYR (R14), G3P→G6P (R8), peptide hydroly-
sis (R64), we need to decide whether OAA→G3P (R15) is
slightly non-zero, or whether OAA→G3P is assumed to
vanish although the optimal is not exactly reached for the
initial flux considered. Despite this difference of struc-
ture between the (HB) dataset and the (Ctrl) and (CN)
datasets, our analysis suggested that extreme distributions
were not biologically relevant, independently from the
ratio of LCFA oxidation or the dataset under study.
Finally, comparing the variability of the AIO coefficients
for the (Ctrl) and (CN) treatments when oxidizing 10% of
Figure 3Modeling long-chain fatty acids oxidation (LCFA) in tricarboxylic acid (TCA) cycle. Introducing LCFA (C(16:0), C(18:0)) oxidation in
the TCA cycle may be required to consistently model the response to several treatments, such as the (HB) dataset (Table 1). In this case, the model
shown in Figure 2 is extended by introducing inputs of C(16:0) (R141) and C(18:0) (R142), and output of C(18:0) (R143). C(16:0) oxidation (R20) and
C(18:0) oxidation (R21) are modified accordingly.
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Table 9 Effect of long-chain fatty acids (LCFA) oxidization in the triacarboxylic acid (TCA) cycle over model analysis
Main properties of the simplex vertices, assuming constant ATP-production,
with different ratios of LCFA oxidized in TCA
Dataset % of FA Model Example of Combinatorics Validation
oxidated name maximized of pathways
in TCA function
R19 R15 R14 R8 R64 R63 R13
NADPH OAA→G3P OAA→PYR G3P→G6P Peptide Peptide Pyr → OAA
oxidation hydrolysis synthesis
(Ctrl)
0%
B v15-v19 0
1831
0 0 0
125
1835
Non
relevant
flux
values
for
R13 ,R64
10% 2451 2455
(CN)
0% 795
150
803
10% 1489 1497
20% 2357 2365
25% 2878 2886
(HB)
10% 6173
150
6145
20% 7115 7086
25% 7675 7646
(Ctrl)
0%
F v14-v19 0 0
1831
0 0
125
1835
Non
relevant
flux
values
for
R13 ,R64
10% 2451 2455
(CN)
0% 795
150
803
10% 1489 1497
20% 2357 2365
25% 2878 2886
(HB)
10% 6173
150
6145
20% 7115 7086
25% 7675 7646
(Ctrl)
0%
D
v8-v19
0 0 0
3662
0
125 4
Non
relevant
flux
values
for
R8 ,R64
10% 4902
(CN)
0% 1590
150 8
10% 2978
20% 4714
25% 5756
(HB)
10%
D1 v8-v19-v14
0
29 0
12289
0 150 0
20% 14172
25% 15292
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Table 9 Effect of long-chain fatty acids (LCFA) oxidization in the triacarboxylic acid (TCA) cycle over model analysis (Continued)
10%
D2 v8-v19-v15 0 29
12289
20% 14172
25% 15292
(Ctrl)
0%
H v64-v19 0 0 0 0
305 430
4
Glucose is
the unique
precursor of
lactose
synthesis
(AIO)
10% 409 533
(CN)
0% 133 283
8
10% 248 398
20% 393 543
25% 480 630
(HB)
10%
H1 v64-v19-v14 0 29 0 0
1024 1174
0
Non
relevant
flux
values
for R63
20% 1181 1331
25% 1274 1424
10%
H2 v64-v19-v15 0 29
1024 1174
20% 1181 1331
25% 1274 1424
(Ctrl)
0%
A v15+v19
669 1714
0 0 0
125
1718
Non
relevant
flux
values
for
R13 ,R64
10% 694 2330 2334
Extreme flux
distributions
within the set of
plausible
solutions
(CN)
0%
22
791
150
799
10% 1485 1493
20% 2353 2361
(HB)
10%
1216
5961
150
5932
20% 6902 6873
25% 7462 7433
(Ctrl)
0%
E v14+v19
694
0
1714
0 0
125
1718
Non
relevant
flux
values
for
R13 ,R64
10% 2330 2334
(CN)
0%
22
791
150
799
10% 1485 1493
20% 2353 2361
25% 2874 2882
(HB)
10%
E1 v14+v19
1216 32 5929
0 0 150
5932
20% 1216 32 6902 6873
25% 1216 32 7462 6920
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Table 9 Effect of long-chain fatty acids (LCFA) oxidization in the triacarboxylic acid (TCA) cycle over model analysis (Continued)
10%
E2 v14+v19-50v15 946 0
6008 5979
20% 6949 6920
25% 7509 7481
(Ctrl)
0%
C v8+v19
694
0 0
3428
0
125 4
Non
relevant
flux
values
for
R8 ,R64
10% 4659
(CN)
0%
22
1583
150 8
10% 2971
15% 4706
20% 5749
(HB)
10%
C1 v8+v19 1216 32 0
11858
0 150
320% 13840
25% 14961
10%
C2 v8+v19-50v15 946 0 29
11958
0
20% 13840
25% 14961
(Ctrl)
0%
G v64+v19
694
0 0 0
286 410
4
Glucose is
the unique
precursor of
lactose
synthesis
(AIO)
10% 388 513
(CN)
0%
22
132 282
8
10% 248 398
20% 392 542
25% 479 629
(HB)
10%
G1 v64+v19 1216 32 0
0
989 1139
3 Non
relevant
flux
values
for
R63 ,R64
20% 1145 1295
25% 1238 1388
10%
G2 v64+v19-50v15 946 0 29
996 1146
020% 1146 1296
25% 1247 1397
Litterature-based upperbounds for fluxes ≤ 591 Non-zero Lower than ≤ 266 mmol/h/half
mmol/ [28,31] whole body udder [33]
h/half udder [33] protein synthesis [29]
To study the impact of the variability of FA oxidation, a ratio of long-chain FA (10%, 20%, 25%) was introduced in the TCA cycle. For datasets (CN), (Ctrl) and (HB) which were compatible with a given ratio of LCFA oxidation,
extreme flux distributions and AIO coefficients variability were studied. Our main conclusions are robust to the introduction of LCFA oxidation (Table 8). Interestingly, as shown in (Table 9), the structure of the simplex
generated by the (HB) diet is more complicated than the (Ctrl) and (CN) treatments, with 13 vertices for all hypotheses. This is due to the fact that R15 is highly constrained by measurements, so that this flux cannot vanish
when R14 is optimized or when R19 is maximized. All the vertices for the (HB)-simplex contradict knowledge-based literature.
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LCFA in the TCA cycle still suggested that the (CN) treat-
ment is characterized by a lower proportion of glucose (on
a carbon basis) which is oxidized in CO2, and a larger ratio
used for lactose synthesis.
Altogether, this study suggests that the main character-
istics of the (Ctrl) and the (CN) treatments are robust and
could be elucidated despite lacking information on the
precise internal behavior of LCFA oxidation.
Discussions
Analyzing the distribution of nutrients in a metabolic
network to study the flexibility of a metabolism at the
organ level
An important challenge in applicational fields of
metabolism studies at the organ level is to understand
how the components of inputs are transformed into some
expected outputs, under some assumptions about the
functioning of a system. To that end, great use is made of
comparisons between yield rates describing the allocation
of input nutrients within the set of outputs. Nonetheless,
to allow a precise comparison of nutrients, these studies
require insights on the distribution of matter components
across the output of each reaction involved in the system.
Such information may be provided by several experi-
mental marking techniques (C13 MFA) that make use of
carbon isotopes [39]. Nonetheless, their application to
mammals is challenging [40].
To elucidate how input nutrients are allocated among
the output nutrients of a metabolic system despite exper-
imental limitations, we have introduced novel methods
which refine the flux balance analysis of a metabolic sys-
tem related to an organ of a large animal. Our method
can be seen as an extension of Flux Variability Analysis
[11], where the emphasize is put on efficiency or yield rate
variability rather than on flux variability.
As an example of application, we have studied the mam-
mary metabolism in ruminants (dairy cows) [15,23,24].
Compared to the conventional models available, our sto-
ichiometric model describes very precisely the variations
of energy consumptions as ATP, allowing us to inves-
tigate some optimization hypotheses related to energy
variations.
As a methodological innovation, we introduced a
method to estimate the Allocation of Inputs in Outputs
(AIO), that is, the ratio of transformation of each input
nutrient into outputs, provided that we are given a flux
distribution balancing the production and consumption
of intermediary metabolites. Two AIO computations are
possible: one may fix a linear combination of flux variable
to optimize, leading to an extreme flux distribution (i.e.
extreme pathways) whose allocations (AIO) are precisely
computed with our method. Alternatively, we can rea-
son with regard to the possibly infinite complete convex
space of plausible flux distributions, in the spirit of FVA
analysis, without solving the set of equations. In this case,
our method estimates the minima and maxima of each
allocation (AIO) coefficient within the complete space.
The latter point is where our main algorithmic inno-
vation lies. Indeed, AIO coefficients are not linear with
respect to the flux variables v. Therefore, they have no rea-
son to be extremal for flux distributions corresponding to
vertices, edges or faces of the simplex, unless the gradi-
ent of every component of the AIO is a nonzero function.
Therefore, we have introduced two algorithms allowing us
to compute the extremal values of AIO coefficients when
the flux space is bounded. The fastest algorithm requires
the exhibition of an analytic expression of the AIOmatrix.
If this is not possible, a local-search algorithm can be
used. These algorithms can be used to check whether the
extremal values are reached for flux distributions lying on
the boundary of the simplex of plausible flux distributions.
This approach applied to a stoichiometry model taking
ATP variations into account permitted a better under-
standing of ruminant mammary gland metabolism in
comparison to previous studies based on similar mod-
els and datasets [22,24]. For instance, we were able to
characterize the differences in the effects of two treat-
ments, such as the quantitative range of the proportion
of glucose which is oxidized in CO2, or used for lactose
synthesis. This information was derived from the carbon
composition of each metabolite, expert knowledge which
is easily accessible and is therefore compatible with the
experimental limitations regarding mammals.
Optimization strategies within tissue or organs
Our study allowed us to revisit optimization-based
hypotheses on the functioning of the mammary
metabolism. We have provided evidence that flux distri-
butions corresponding to an optimal production of energy
(ATP) cannot describe appropriately the metabolism of
the mammary gland, as would be the case for bacterial
metabolisms, which tend to optimize biomass-related
functions [5,41]. The main reason is that the ATP balance
is too large and variable among the responses to different
treatments, confirming previous observations [31]. As a
consequence, the underlying hypotheses used to drive
previous studies of mammary metabolism have to be
carefully reformulated [15,21,23].
As an alternative, we have hypothesized that ATP bal-
ance remains nonoptimal and almost constant in response
to several treatments, and we have introduced in the
model a recent estimation for this quantity [31]. Our goal
was to check whether the observed responses to the sys-
tem could be explained by the optimization of a linear
combination of fluxes, that is, an extremal vertex of the
simplex of plausible flux distributions. This hypothesis
was rejected, first because it led to non-realistic orders of
magnitude for some fluxes such as peptide hydrolysis, and
Abdou-Arbi et al. BMC Systems Biology 2014, 8:8 Page 20 of 26
http://www.biomedcentral.com/1752-0509/8/8
second because the precursors of some components such
as glucose were not biologically relevant [26,27]. Notably,
it was necessary to trace back the quantitative origin of the
nutrients to complete this analysis and reject all extreme
flux distributions, illustrating the advantage of the AIO
approach.
Therefore, no optimization of a linear combination of
flux variables could be found to uniquely describe the
metabolism of the mammary gland, a multicellular organ,
as an extreme flux distribution of our model. To overcome
this limitation of FBA-inspired analyses at themammalian
tissue or organ level, we studied the variability of AIO
coefficients by introducing the computation of min-max
ranges of AIO. This led to a general overview of the effects
of treatments without precluding any steady state internal
behavior.
Benefits of studying the variability of the allocation of
input in output (AIO) and future model refinements
The study of the variability of AIO, that is, intervals of
allocation of nutrients, made it possible to distinguish the
metabolism of the mammary gland in two different nutri-
tional conditions corresponding to an increase in protein
supply (Ctrl and CN). Notably, the intervals of allocation
of glucose in CO2 and lactose were different in the two
nutritional conditions, reflecting the mammary gland’s
metabolic flexibility. Nonetheless, several improvements
can be made to the model.
First, the simplex of plausible distributions could be
reduced by introducing knowledge currently available
on the kinetic bounds for enzymatic activities, intro-
duced in previous numerical models [21]. This may for
instance prevent some non-constrained behaviors shown
in Tables 6 and 7, such as the possible nonzero contri-
bution of acetate and β-hydroxybutyrate (BHBA) carbon
to lactose. The main issue in this area will be to aggre-
gate the enzymatic knowledge to fit with the format of
the reactions in the model, such as the reaction R6 which
transforms G3P to PYR under the regulation of five differ-
ent enzymes, together with NAD+ and ATP availability.
Therefore, proposing relevant maximal values requires
the use of advanced methods for model reductions.
A second improvement of the model is dependent on
the production of additional observations to clarify the
set of possible behaviors of the system. Particularly, the
contribution of acetate and β-hydroxybutyrate (BHBA)
to lactose shown in Tables 6 and 7 remains question-
able in ruminants since it suggests that the carbon of
acetyl-COA could leave the TCA cycle of the mitochon-
dria through the OAA → G3P pathway. This could be
explained by the fact that the carbon allocation in the
model did not take account of the carbon positions. How-
ever, one isotope model and one study of gluconeogenesis
in man suggested that labeled carbon within glucose came
from [ 2− 14C]-acetate (through 14C-acetylCoA in TCA)
[42,43]. It remains challenging to obtain such precise
information for large ruminants such as dairy cows. Nev-
ertheless, the model could be improved by modeling with
additional constraints the few items of knowledge we have
on the flux distribution of positioned carbons.
The last improvement of the model consists of includ-
ing constraints that do not correspond to rule-based
metabolic equations. More precisely, in several numeri-
cal models, the effects of external fluxes were introduced
to predict the response of the mammary gland in a con-
sistent way [14,17,18]. Among external fluxes, we noticed
the regulatory effect of long-chain fatty acids on the activ-
ity of enzymes involved in fatty acid synthesis, although
themechanisms are not clearly understood [44]. Although
some extensions of the FBA formalism to dynamic reg-
ulation exist [45], the data availability was insufficient to
apply the extensions in the model. Therefore, existing reg-
ulations of enzyme activities cannot be included directly
in the stoichiometric model. To overcome this limitation,
we plan to investigate the effects of external fluxes by
introducing additional constraints in the model, to check
whether the nutrient output in the milk can be predicted
from the nutrient input.
Conclusion
We have introduced a method in the framework of flux-
balance analysis of a metabolic network. As a main nov-
elty, our approach allows studying the variability of effi-
ciencies (or yield rates) of a metabolic model provided
with input-output measurements. More precisely, our
approach allows a quantitative estimation of theminimum
and maximum proportions of the carbon quantity of each
input nutrient which is recovered in each output compo-
nent of the system. The main innovation is to propose a
method which does not require determining the quantita-
tive distribution of nutrients between the branches of the
system. To that end, we have performed a parsing of the
space of flux distributions which are compatible with both
themodel stoichiometry and input-outputmeasurements.
This method was applied to study the response of the
mammary gland to several treatments. It allowed us to
distinguish two different metabolic responses of the sys-
tem, corresponding to two nutritional situations and accu-
rately reflecting metabolic flexibility. Overall, our method
appears to be configured to study the variability of the
yield rates of a metabolic system at the multicellular or
organ level without making any hypothesis on the internal
behavior of the system.
Method
Flux modeling based on Flux Balance Analysis
Metabolic models are described according to the generic
framework of Flux Balance Analysis [6,25,46]. Metabolites
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split into three non-intersecting sets. First, input metabo-
lites are gathered in set I . The rate vector of all input
fluxes (with in the form “→ I”) is denoted by vI ∈ R
p. Sec-
ond, output metabolites are denoted by O. We denote by
vO ∈ R
q the rate vector of the corresponding output fluxes
(in the form “O→”). Finally, intermediary metabolites (or
pivots) are denoted by P , and its cardinality is denoted by
n. The complete set of metabolites is M = I ∪ P ∪O ={
m1 . . .mp+n+q
}
.
Let R = {r1 . . . rt} be the set of t reactions which pro-
duce some metabolites while degrading others. The rate
vector of these reactions is denoted by v ∈ Rt . A reac-
tion rj has the form
∑
m∈I∪P sm,jm −→
∑
m′∈P∪O s
′
m,jm
′
where sm,j and s
′
m,j are input and output stoichiometric
coefficients. The metabolic system is described by the so-
called stoichiometric matrix M = (ai,j)i≤p+n+q,j≤r , where
ai,j = s
′
mi,j
− smi,j.
As a usual assumption, intermediarymetabolites cannot
accumulate in the cell: the consumption and production
flux rates of intermediary metabolites are balanced. A
linear constraint is derived on the rate vector v ∈ Rt .
Additional biological knowledge about the distribution
of fluxes within the system is modeled by a matrix B.
Overall, plausible flux distributions v satisfy the following
equations:
M
⎛
⎝−vIv
vO
⎞
⎠ = 0 [Stoichiometry constraints];
Bv = 0 [Biological knowledge constraints].
(1)
Assuming that reactions are irreversible and fluxes have
physical upper-bounds, the set of solutions to Eq.(1) is
a convex polyhedron, called a simplex, of plausible flux
distributions. The simplex can be described by means of
its vertices, edges or faces [6,25,46], which are related to
the optimization of objective functions and have shown
their biological significance in several contexts [47]. In
the example described below, vertices of the simplex (i.e.
extreme pathways) were computed with standard linear-
based methods in the bound case, and with probabilistic
methods in the unbound case. As a refinement of these
methods, we used a random sampling of the set of possible
linear objective functions to obtain a complete descrip-
tion of the set of extreme pathways. This approach was
efficient since the dimension of the space of feasible dis-
tribution is quite small, because it is strongly constrained
by the input-output vectors vI and vO.
Modeling the quantitative contribution of input
metabolites to output nutrients: AIO
In studies at the organ level such as in nutrition, the
choice of a plausible flux distribution v aims to elucidate
how an input nutrient may contribute to the composi-
tion of an output product. To formalize this issue, we
introduce a component according to which the allocation
of input nutrients will be computed. For dietary applica-
tions, carbon is a relevant element since it appears in the
composition of all metabolites in the system. Nitrogen is
less generic but more relevant when specifically studying
nitrogenmetabolism. Our issue therefore reads as follows:
how much carbon introduced into the system through a
given input flux can be recovered in the rate of production
of an output metabolite?
We introduce the following formalism. Let c ∈ Rp+n+q
be a vector describing the component composition of
metabolites (its carbon composition for instance). Assume
that the stoichiometry of each reaction in the system
satisfies a matter-invariant property with respect to the
component, that is:
∑
mi∈M
ai,jc(mi) = 0 for every reac-
tion rj ∈ R. Of the total component mass provided as
a substrate to a reaction r, only a part contributes to the
composition of a given product m. Let Inr(m) denote this
ratio. Assuming that the system follows a proportional
matter distribution, a consequence of the mass-invariant
property is that
∑
m∈M In
r(m) = 1 for all r ∈ R.
Let v be a plausible flux distribution and a, solution to
Eq.(1). Let m be an input metabolite, for example glu-
cose. The rate of the flux of component mass brought
into the system by m equals C(m)vI(m). We denote by
xO[ v,m]∈ R
q the vector of proportions of input compo-
nent fluxes recovered in each output flux (for instance, the
proportion of carbon from the input glucose appearing in
the composition of the CO2 in blood). The coefficients of
xO[ v,m] are called the allocation of the metabolite m in
output nutrients.
To determine these ratios, we introduce xP[ v,m]∈ R
n
the vector of ratios of input component fluxes which
are required to produce each intermediary metabolite
m before its breakdown into other metabolites. The
law of matter conservation and the assumption that
intermediary metabolites do not accumulate put sev-
eral constraints on xP[ v,m] and xO[ v,m], which are
detailed in Tables 8 and 9. We deduce that the vec-
tor of allocations xO[ v,m] is a solution to the equation
D2[ v] x
(m)
I = −D1[ v]
(
xP[ v,m]
xO[ v,m]
)
for the input param-
eter vector x
(m)
I = (0, . . . , 0,C(m)vI(m), 0, . . . , 0), where
D1 and D2 are defined in Table 10. To elucidate whether
this system of matrices determines uniquely xO[ v,m], we
noticed that D1 is a square matrix such that all diagonal
coefficients are equal to 1 and the others are nonpositive.
This family of matrices is named the M-matrix in [48],
and it has been shown that such a matrix is invertible. We
deduce that D1 is invertible so that the vectors of allo-
cations xO[ v,m] and xP[ v,m] are determined uniquely.
With these formulas, when the flux distribution v has been
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Table 10 Modeling the quantitative allocation of input nutrients in output products
Inr(mk) =
⎧⎨
⎩
ak,jC(mk)∑
mi∈M,ai,j<0
|ai,j |C(mi)
if ak,j > 0
0 otherwise.
Ratio of the flux of component c provided as substrate to a
reaction rj recovered in the composition of the product mk . It
is the sum of individual substrate contributions.
F(mi) =
∑
rη∈R,ai,η>0
ai,ηvη =
∑
rη∈R,ai,η<0
|ai,η|vη Total metabolite rate involved in the production of an interme-
diary metabolitemi , before its degradation by other reactions
dk,i =
⎧⎪⎨
⎪⎩
1 if k = i
−
∑
rj∈R,ai,j<0
|ai,j |vj
F(mi)
∗ Inrj (mk) otherwise.
Ratio of a product flux (mk ∈ P ∪ O) on the production of
mi ∈ I ∪ P ∪ O
D1[ v] = (dk,i)p<k,i≤p+n+q Linear transformation of matter components contained in
intermediary or output metabolites
D2[ v] = (dk,i)p<k≤p+n+q,1≤i≤p Linear transformation of matter component contained in input
metabolites
x[ v,m] =
⎛
⎜⎜⎝
x
(m)
I
xP[ x,m]
xO[ x,m]
⎞
⎟⎟⎠ Rates of fluxes of component brought by the m-input flux
appearing in the composition of each metabolites. x
(m)
I =
(0, . . . , 0, C(m)vI(m), 0, . . . , 0).
D2[ v] x
(m)
I = −D1[ v]
⎛
⎝ xP[ x,m]
xO[ x,m]
⎞
⎠ Constraints on component fluxes deduced from the matter-
invariance law, derived from Eq.(2) below.
We are given a stoichiometric matrix A and a vector c ∈ Rp+n+q which describes the component composition of all metabolites. If v is a fixed flux distribution which is
compatible with the stoichiometry of the system, AIO[ v] is a matrix whose (i, j) input describes the proportion of component quantity contained inmi which is
recovered in the flux of the outputm.
x[ v,m] (mk) =
∑
rj∈R,ak,j>0︸ ︷︷ ︸
reactions
producingmk
Inrj (mk)︸ ︷︷ ︸
proportion of component
flux brought to the
composition ofmk
throughrj
×
∑
mi∈M,ai,j<0︸ ︷︷ ︸
substrate ofrj
|ai,j|vj
F(mi)︸ ︷︷ ︸
Proportion of
mi − component
consumed byrj
× x[ v,m] (mi)︸ ︷︷ ︸
rate of the flux of
component
appearing in
the composition ofmi︸ ︷︷ ︸
total flux of component provided as substrate torj
(2)
chosen, any algorithm or method to inverse matrixD1 can
be used.
Overall, the complete table showing the distribution of
nutrient inputs in nutrient outputs is defined to be the q×
pmatrix AIO[ v], the columns of which are xO[ v,m1], . . . ,
xO[ v,mp], as follows:
AIO[ v] = xO[ v,m] .(
xP[ v,m]
xO[ v,m]
)
= −D1[ v]
−1D2[ v]
×
⎛
⎜⎝
C(m1)vI(m1) 0
. . .
0 C(mp)vI(mp)
⎞
⎟⎠ .
(3)
With these formulas at hand, as soon as the flux distribu-
tion v has be chosen, any algorithm or method to inverse
the matrixD1 can be used. Altogether, the computation of
a complete AIO table takesO((n+p+q)3+np) operations
for a given flux distribution v.
Computing extrema of the AIO coefficients among the
complete polyhedron of plausible flux distributions:
solving nonlinear optimization problems
Computing the extrema of the AIO coefficients among the
convex polyhedron of plausible flux distributions v, leads
to an optimization problem in a nonlinear context. The
problem rewrites in an optimization scheme, leading to
2q× p optimization problems of the form
∀i ≤ q, ∀k ≤ p, (Max/Min)imize⎧⎨
⎩AIO[ v] [ i, k] ; v ∈ Rn, M
⎛
⎝−vIv
vO
⎞
⎠ = 0, Bv = 0, v ≥ 0
⎫⎬
⎭ .
(4)
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These problems are nonlinear programming (NLP) prob-
lems [49] since they aim to optimize a nonlinear objec-
tive function over a possibly nonbounded simplex search
space.
When both the simplex search space was bounded and
an analytical expression forAIO[V ] as a function of all the
free variables of the eq.(1) solution space was producible
with formal algebra software [50], the Matlab fmincon
function was used to solve the NLP problem. Among
all available optimization routines, the best performance
was achieved by the interior point algorithm, which has
a polynomial complexity for these problems [51]. Other
optimization routines were used to confirm our results,
but the computation time was much longer.
When an analytical expression was not available, we
implemented an alternative strategy making use of some
local search routines together with the fact that AIO(v)
can be computed for any v in a cubic time. First, we
compute the Chebyshev ball B(x0, r) of the simplex [52].
Any point x of the n-dimensional ball is uniquely iden-
tified by a vector (θ1, . . . , θn) with θi ∈[ 0, 2pi [ for 1 ≤
i < n and θn ∈[ 0,pi [. The intersection P(x) of the half
line [ x0, x) with the simplex of plausible flux distribu-
tions is unique if it exists. Conversely, for any point y
on the boundary of the simplex, there exists a unique
x ∈ B(x0, r) such that y = P(x). By extension, we say
that (θ1, . . . , θn) is a parameterization of the boundary of
the simplex. This parameterization is used to determine a
discretization of the simplex boundary. Given an integer
p > 0, every θi is assumed to be of the form 2pi j/p, for
j ∈ {0, . . . , p − 1}, whereas θn rewrites as pi j/p. The finite
neighborhood of any point y on the boundary, denoted
by N (y) is obtained by modifying each single coordi-
nate of the parameterization (θ1, . . . , 2pi j/p, . . . , θn) of y:
for instance, among the maximal 2n neighbors, we find
the point with paramerization (θ1, . . . , 2pi(j−1)/p, . . . , θn)
and (θ1, . . . , 2pi(j + 1)/p, . . . , θn). We can finally apply a
local search algorithm based on a dichotomy principle to
improve the discretization level and reach the solution to
the optimization problem on the simplex boundary.
The same algorithm is extended to the full space by
introducing a supplementary coordinate standing for the
distance between P(x) and the center x0 of the Chebyshev
ball. This makes it possible to check whether the optimum
identified previously lies on the boundary of the simplex.
Analysis workflow
A web application dedicated to the computation of AIO
for metabolic networks is freely available [53]. It enables
us to build a stoichiometric model, define its inputs and
outputs, solve the associated FBA problem and finally
compute the AIO of the selected flux distribution. Offline
tools enabling the computation of the extrema of the AIO
are also provided in a companion web pagee.
The complete workflow of analysis requires the online
webpage together with the use of several environments.
First, php is required for the computation of extremal ver-
tices of the convex polyhedron of plausible flux distribu-
tions, including the case when this space is not bounded.
Second, SAGE is used to performed formal algebra tasks
involved in the computation of AIO matrices. Finally,
matlab is needed to compute the extrema of the AIO
coefficients. The main functionalities of the workflow are
depicted in Figure 2.
Mammary gland stoichiometry model
As the basis of the ruminant mammary gland metabolism
that is studied in this paper, we used a generic model of
mammary metabolism [15,23]. This generic model con-
tained 54 reactions involving six intermediary metabo-
lites, called carbon-chain pivots, at cross-over points
between metabolic pathways, chosen to describe the main
possible conversions between metabolites: oxaloacetate
(OAA), α-ketoglutarate (α-KG), pyruvate (PYR), acetyl
coenzymeA (AcoA), glucose (GLC) and serine (SER pivot).
The reactions also take into account the variations in ATP,
four cofactors (NADHc, NADHm, NADPH and FADH2)
and other metabolites (O2, CO2 and NH3).
The model was first extended and detailed in order
to include the reactions included in other models of
mammary metabolism [15,21,22,24]. Reactions for lac-
tose synthesis, milk protein, fatty acids and glycerol-3P of
triglycerides were included in the model, as well as four
new pivots. Mitochondrial (mAcoA) and cytosolic (cAcoA)
acetyl-CoA were used to distinguish between utilization
of cACoA for fatty acid (FA) synthesis and utilization of
mACoA in the tricarboxylic acid (TCA) cycle. In addition,
glucose-6-phosphate (G6P) and triose-phosphate (G3P)
were introduced to account more specifically for the
transformation of glucose through the pentose phosphate
pathway, lactose synthesis and glycerol-3P utilization. For
lipid metabolism, three new intermediary metabolites
were introduced (Glycerol-3P) and two fatty acid primers
(Primer (C2:0)CoA and Primer (C4:0)CoA). They corre-
spond to the primers of two (from acetate) or four (from
β-hydroxybutyrate; BHBA) carbon-units necessary to ini-
tiate fatty acid synthesis before elongation, since in rumi-
nant mammary glands fatty acids are synthesized from
acetate or BHBA and not glucose. Other additional reac-
tions were included to describe milk synthesis, such as
NADPH synthesis through the isocitrate dehydrogenase
pathway. The input (net uptake) of long-chain fatty acids
was not considered in the system since these are not syn-
thesized by the mammary gland and we hypothesized
that they are not oxidized within the mammary gland
of lactating animals, as measured in well-fed goat and
nonruminant through isotopes [35,37]. This hypothesis
was sustained by carbon balance measurements based on
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experimental measures of CO2 [28]. This latter hypoth-
esis was relaxed in a second step (see Figure 3) to study
how our results are impacted by the introduction of oxi-
dation of long-chain fatty acid within TCA cycle, as mod-
eled in alternative contexts [18,20-22]. In addition, the
action of long-chain fatty acids to regulate enzyme activ-
ities involved in C(4:0) . . . C(16:0) production was taken
into account by the fact that C(4:0), . . . C(16:0) fluxes of
synthesis are explicitly given in the dataset.
Protein synthesis was summarized by the number of
peptide links synthesized (peptide synthesis) and the ATP
required for each peptide synthesis was fixed at 5 in the
present model [23]. Similarly, protein degradation was
summarized by the number of hydrolyzed peptide links
(peptide hydrolysis). The ATP consumption for each pep-
tide hydrolysis was set at a single ATP [54].
Finally, four output reactions were included in the
model in order to calculate the overall allocations in car-
bon (R137), nitrogen (R138), CO2 (R139) and Serine (R135).
As a last step, this model was restricted to the case
of ruminants. Some reactions, such as fatty acid oxida-
tions (R20 to R23) and pyruvate synthesis through malic
enzyme R66) and some input and output fluxes present in
the generic stoichiometricmodel [23] were not considered
to occur in ruminant mammary glands (fructose (R25);
glucose production from G6P neoglucogenesis (R10), ace-
tone synthesis (R69), BHBA synthesis (R70), acetoacetate
synthesis (R71), and ureogenesis (R50).
Altogether, this mammary gland model contained 140
reactions, involving eleven intermediary metabolites, four
cofactors and ATP, CO2, O2 and NH3. The stoichiometry
of the system implies that the balance (production minus
consumption) of these four last outputs can be uniquely
deduced from the choice of a plausible flux distribution.
The full model is shown in Figure 2 and the corresponding
stoichiometric model is provided in the supplementary
webpage (SBML format).
Additional information: datasets, inputs, outputs,
additional knowledge, component
Two datasets [28,29] were used, in relation to the response
of dairy cow mammary gland metabolism to some
increases in the protein supply: a control diet (Ctrl) and
increased protein supply through casein infusion into
the duodenum (CN). A complementary dataset (HB),
previously used in a mechanistic model of the mam-
mary metabolism, was used as a reference response [21].
Datasets are shown in Table 1. All data were converted
into mmol/h/half udder.
Fluxes of nutrients taken up on a net basis by the mam-
mary gland were considered as inputs whereas fluxes of
nutrients produced in milk, such as lactose, milk protein,
milk fatty acid arranged in triglycerides or CO2 pro-
duced and released in blood, were considered as outputs.
Special attention was paid to amino acid inputs and out-
puts, milk protein output, fatty acids synthesized within
the mammary gland and total triglyceride output accord-
ing to established calculation rules [21,30]. Milk proteins
were modeled by their number of peptide links (peptide
output). The amino acid inputs or outputs corresponded
to the balance between their real net uptake minus their
contribution to peptide outputs (utilization in milk pro-
tein). When the balance of an amino acid was positive, it
corresponded to an input flux. When it was negative, it
corresponded to an output flux (see Table 1). Two input
reactions were also assumed to be inactive in all data
sets since the corresponding net uptake were not mea-
sured in the datasets (Table 1): propionate input (R28)
and triglyceride hydrolysis (R65) in long-chain fatty acids
input.
Eight additional linear constraints were introduced to
the fluxes to ensure that the model was relevant bio-
logically [21]. These are detailed in Tables 4 and 5 and
allow building matrix B appearing in Eq.(1)f. The rate of
fatty-acid acylCoA (C(n:m)-acylCoA) was fixed to be three
times higher than the triglyceride output, assuming that
100% of milk lipids are triglycerides: it included all fatty
acid acylation, that is, fatty acid synthesized in the mam-
mary gland and long fatty acid taken up. 50% of fatty acids
were assumed to be synthesized from acetate, i.e. from
primer C(2:0)CoA and the other 50% from BHBA (primer
C(4:0)CoA), with the exception of C(4:0) fatty acid, which
was supposed to be synthesized only from BHBA. It was
assumed that 30% of NADPH was generated by the isoc-
itrate desydrogenase pathway and 70% of NADPH was
generated in the pentose phosphate pathway [21].
Carbon was the component chosen to compute and
analyze the allocation of nutrient inputs in nutrient out-
puts. The stoichiometry of the metabolic network satisfies
the mass-invariant property according to this component.
This required a very precise description of CO2 produc-
tion and consumption in the model reactions and was
validated with external measurements of the CO2 balance
provided with the datasets.
Availability of supporting data
The datasets supporting the results of this article are
included within the article (Table 1). The SBML file
for the mammary gland model and tools enabling the
computation of all results are provided in a com-
panion web page: http://nutritionanalyzer.genouest.org/
SupplementaryMaterial.
Endnotes
aThese functions are: v8 + v19, v8 − v19, v14 + v19,
v14 − v19, v15 + v19, v15 − v19, v64 + v19, v64 − v19
bFor instance, for the (Crtl) treatment, there is a
distribution such that v8 < 591 and v13 < 266 are lower
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than the bounds introduced in [26,27], while
v64/v63 = 0.62 < 0.67 and glucose is the precursor for
90.79% of the lactose carbon
cAll the computations were performed by usingMatlab
release 2011 on a Xeon E5645 multicore computer.
dThese functions are: v8 + v19, v8 + v19 − 50 v15,
v8− v19− v14, v8− v19− v15, v14+ v19, v14+ v19− 50 v15,
v14 − v19, v15 + v19, v15 − v19, v64 + v19,
v64 + v19 − 50 v15, v64 − v19 − v14, v64 − v19 − v15.
ehttp://nutritionanalyzer.genouest.org/
SupplementaryMaterial. The access to the pre-formatted
model and datasets supporting the results is planned to
be on request. A valid access is provided by: login :
SuppMat; password : tamppuss
fMathematically, these constraints can be derived as:
0.7v82 − 0.3v58 = 0; v51 − v52 = 0; v54 − v90 = 0;
v55 − v91 = 0; v86 − v92 = 0; v87 − v93 = 0; v88 − v94 = 0;
v56 − 3v62 = 0.
Additional file
Additional file 1: SBML version of the metabolic model. The complete
metabolic model of mammary gland metabolism is provided in the free
and open standard SBML representation format (Systems Biology Markup
Language).
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